About Prosper Health
Prosper Health is a telehealth provider for autistic and neurodivergent adults. Licensed psychologists assess adults for autism over video, and Prosper's therapists offer ongoing therapy adapted to neurodivergent clients. It is in network with Aetna, Blue Cross Blue Shield, Cigna, Oscar, Oxford and UnitedHealthcare in 31 states.
Prosper started in 2023 and is headquartered in Weston, Florida, according to Behavioral Health Business. Benjamin Schecter is CEO. Prosper has served 30,000 clients, and its job listings show it has more than 400 clinicians. Its chief clinical officer, Rachel Loftin, PhD, is on the psychiatry faculty at Northwestern and Yale. In July 2026, Headspace named Prosper one of four new specialty care partners.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Sep 10, 2026 | $10,029,002fully sold | 6 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Jan 3, 2025 | Jan 22, 2025 | $16,234,237fully sold | 32 | $507K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $26,263,239 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by Prosper Health
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|
Why Investors Backed Prosper Health
Investors backed Prosper Health because autistic adults are a large group with few places to get care. Many autism services end at age 21, yet adult diagnoses are rising fast. Prosper sells virtual testing and therapy that major insurers cover in 31 states, and it is growing threefold a year. Lexi Henkel of Maverick Ventures, which led its Series A, called neurodivergent adults "a large and underserved population."
The problem it targets
Autism care in the US centers on children. Behavioral Health Business (BHB) notes that autism therapy focuses almost entirely on early intervention. Adults have far fewer options. One study cited by BHB found that 70% of therapists say they do not know enough about autism. Prosper's job posts add that diagnoses rose more than fivefold in 25 years, while autistic adults stayed "systematically overlooked." Spice Capital, an early investor, put it simply: "Demand for autism care dramatically exceeds specialist supply."
What the product does
An autism assessment at Prosper takes two 90-minute video sessions with a licensed psychologist, then a feedback session and a written report. In a few states, it also tests for ADHD alongside autism. Clients can see a Prosper therapist with or without a diagnosis. Self-pay prices are $950 per assessment and $125 per therapy session, but most clients pay less than $80. A BBG Ventures recap of a Kindred Ventures event said Prosper uses AI to cut a 20-hour diagnostic process to five hours. Next, Prosper plans to add medication management by the end of 2026.
Progress so far
Prosper has served 30,000 clients. It is growing threefold a year, with run-rate revenue in the "mid-double-digit millions" and more than 400 clinicians. One posting plans to grow from about 800 clinicians to more than 1,500. In October 2026, Prosper staff and a UMass Chan researcher published a study of 100 adults. A blinded outside expert matched the clinicians' autism calls in 86% of cases.
Who backs it
Maverick Ventures led Prosper's Series A in 2025, Business Insider reported. Lexi Henkel, now a managing director there, sourced the deal and joined the board. "Over time, I became increasingly convinced that neurodivergent adults represented a large and underserved population," she told Business Insider. Spice Capital invested in 2023 and names Haystack and Kindred Ventures as co-investors. BHB reported a $16.2 million raise in January 2025 and about $10 million more in September 2026.
How the market is moving
Adult diagnoses keep climbing. A study of medical records found that diagnoses among adults aged 26 to 34 rose 452% from 2011 to 2022, according to BHB. In July 2026, Headspace added Prosper, Charlie Health, Cortica and Equip as specialty partners. Nearly a third of its referral requests were for high-need specialty care. In September 2026, Sword agreed to buy Headspace for up to $300 million in cash, HIT Consultant reported. Investors also back other autism startups, such as Frontera Health, which raised a $32 million seed round in February 2025.
We wrote this summary from public statements by Prosper Health and its investors. It is not investment advice.
Prosper Health in the News
- Diagnostic Agreement of a Structured Telehealth Adult Autism Assessment
- Prosper Health Raises $10M to Support Adults with Autism
- Headspace Teams Up with 4 Companies for Specialty Care
- Headspace Expands Specialty Care Ecosystem via Partnerships with Charlie Health, Cortica, Prosper, and Equip
- Rise of Digital Adult Autism Services Reveals Blind Spots for Behavioral Health Industry
- Neurodivergent Affirming Therapy Provider Prosper Health Lands $16M for Telehealth Platform
Leadership Team
Executive officers and directors listed on Prosper Health's Form D filed Sep 10, 2026.
Earlier filings also listed Lexi Henkel (director, last listed Jan 2025).
Sources
- SECProsper Health, Inc. filing history
- Companyprosperhealth.io, FAQ (insurers and 31 states, prices, assessment steps, no Medicare or Medicaid)
- Companyprosperhealth.io, privacy policy (Prosper Health, Inc.)
- Companyprosperhealth.io, terms of use (Prosper Health, Inc.; Delaware law)
- Companyprosperhealth.io, reviews page (97% satisfaction)
- CompanyProsper Health careers board
- CompanyProsper Health job post, GM, New Verticals (growth, run-rate revenue, clinicians, team background)
- CompanyProsper Health job post, psychiatric nurse practitioner (medication management by end of 2026)
- CompanyProsper Health job post, Strategy & Operations Lead, People (about 800 to 1,500+ clinicians)
- Investormaverickcapital.com, Maverick Ventures team (Lexi Henkel) and portfolio (Prosper Health)
- Investorspicecapital.xyz, portfolio (co-investors Haystack and Kindred Ventures)
- Investorspicecapital.xyz, case studies (invested 2023; thesis)
- PressBusiness Insider, rising-star VCs (2026-02-03): Henkel led Prosper's Series A
- PressBehavioral Health Business (2025-02-19): Frontera Health $32M seed
- PressHIT Consultant (2026-09-16): Sword to acquire Headspace
- PressBBG Ventures, The Modern Healthcare Stack (2025-10-29): AI in Prosper's diagnosis
- ResearchEurope PMC record of the study (abstract, author affiliations)